Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Palm Beach BIO is a national network of CAP-accredited and CLIA-certified pathology and molecular laboratory partners. The company provides access to human biomaterials, data, pathology consultation, digital pathology review, assay validation, AI-based analytics, and an extensive menu of laboratory tests for pharmaceutical, biotech, diagnostics companies as well as academic researchers. Their offerings accelerate personalized medicine research by providing biospecimens (including FFPE samples), advanced molecular testing (NGS/PCR/IHC/FISH/flow cytometry), digital imaging/AI analysis capabilities, and expert board-certified pathologist consultations across multiple subspecialties.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Palm Beach BIO.